Nanolyze

Nanolyze is a Swedish life science tools company developing patented analytical instruments for label-free, real-time analysis of nanoparticles at single-particle resolution. Its technology is aimed at nanomedicine, drug-delivery, diagnostics, and quality-control workflows, helping researchers study exosomes, viruses, lipid nanoparticles, protein corona formation, particle binding kinetics, and cargo loading. The company markets products including Nanolyze Explore, Nanolyze Sense, Nanolyze Analytix, and Nanolyze Vision, with the latter positioned as a more automated system for diagnostic and GMP/QC settings. Nanolyze is based at AstraZeneca BioVentureHub in Mölndal, Sweden, and appears to operate as a private, venture-backed startup founded in 2020. Rather than developing therapeutics, it provides enabling instrumentation and software for biotech, pharma, and academic researchers working in nanoscience and nanomedicine.